194 related articles for article (PubMed ID: 10928955)
1. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction.
Matsunaga Y; Shono M; Takahashi M; Tsuboi Y; Ogawa K; Yamada T
Br J Pharmacol; 2000 Aug; 130(7):1539-46. PubMed ID: 10928955
[TBL] [Abstract][Full Text] [Related]
2. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation.
Peterson CG; Skoog V; Venge P
Immunobiology; 1986 Mar; 171(1-2):1-13. PubMed ID: 2940166
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of eosinophil cationic protein release in the serum: role of adhesion molecules.
Kato Y; Fujisawa T; Terada A; Iguchi K; Kamiya H
Int Arch Allergy Immunol; 1999; 120 Suppl 1():60-4. PubMed ID: 10529607
[TBL] [Abstract][Full Text] [Related]
5. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
Horie S; Kita H
J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
[TBL] [Abstract][Full Text] [Related]
8. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
Xu X; Håkansson L
Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
Kawaji K; Matsunaga Y; Kido H; Ogura T
Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil granule proteins activate human heart mast cells.
Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils.
Kawashima T; Iwamoto I; Nakagawa N; Tomioka H; Yoshida S
Int Arch Allergy Immunol; 1994; 103(4):405-9. PubMed ID: 8130655
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
Egesten A; Blom M; Calafat J; Janssen H; Knol EF
Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
[TBL] [Abstract][Full Text] [Related]
15. Effect of loratadine on human eosinophil function in vitro.
Eda R; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
Ann Allergy; 1993 Oct; 71(4):373-8. PubMed ID: 8214802
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils.
Bankers-Fulbright JL; Kephart GM; Bartemes KR; Kita H; O'Grady SM
J Cell Sci; 2004 Nov; 117(Pt 24):5749-57. PubMed ID: 15507482
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
Winqvist I; Olofsson T; Olsson I
Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
Tohma S; Lipsky PE
J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
[TBL] [Abstract][Full Text] [Related]
19. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
Egesten A; Gullberg U; Olsson I; Richter J
J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
